EUDA Health (EUDA) Expected to Announce Quarterly Earnings on Tuesday

EUDA Health (NASDAQ:EUDA) is expected to be issuing its results before the market opens on Tuesday, July 28th. Analysts expect EUDA Health to announce earnings of $0.40 per share and revenue of $9.6090 million for the quarter.

EUDA Health (NASDAQ:EUDA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.20) by $0.76. The business had revenue of $1.92 million during the quarter, compared to analysts’ expectations of $3.90 million.

EUDA Health Price Performance

NASDAQ:EUDA opened at $14.48 on Tuesday. EUDA Health has a 52-week low of $5.26 and a 52-week high of $86.00. The stock has a fifty day moving average of $15.01 and a 200 day moving average of $17.77.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health as of its most recent SEC filing. Hedge funds and other institutional investors own 4.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on EUDA shares. Weiss Ratings lowered EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. Zacks Research upgraded shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, EUDA Health currently has an average rating of “Hold” and a consensus target price of $55.00.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.